The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koehn, B.
Right arrow Articles by Larsen, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koehn, B.
Right arrow Articles by Larsen, C. P.
The Journal of Immunology, 2006, 176: 2691-2696.
Copyright © 2006 by The American Association of Immunologists


BRIEF REVIEWS

Patients, Pathogens, and Protective Immunity: The Relevance of Virus-Induced Alloreactivity in Transplantation

Brent Koehn*, Shivaprakash Gangappa*, Joeseph D. Miller{dagger}, Rafi Ahmed{dagger} and Christian P. Larsen1,*

* Emory Transplant Center, Department of Surgery, and {dagger} Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322

Successful transplantation requires the establishment of an ongoing state in which there is simultaneous inhibition of the undesired T cell-dependent rejection response and yet retention of the ability to develop effective cell-mediated primary and memory responses to pathogens. The complexity of attaining such a precarious state is underscored by the growing body of evidence that alloreactivity can be profoundly influenced by infections that occur before, concurrent with, or subsequent to an organ transplant. In this review, we explore the growing list of mechanisms that have been identified by which pathogen-host interactions might influence rejection, including the degeneracy of TCR recognition leading to cross-reactive immune responses, the effects of pathogens on innate immune mechanisms, and the potential impact of virally induced lymphopenia.




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. H. Koehn, M. A. Williams, K. Borom, S. Gangappa, T. C. Pearson, R. Ahmed, and C. P. Larsen
Fully MHC-Disparate Mixed Hemopoietic Chimeras Show Specific Defects in the Control of Chronic Viral Infections
J. Immunol., August 15, 2007; 179(4): 2616 - 2626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Salama, K. L. Womer, and M. H. Sayegh
Clinical Transplantation Tolerance: Many Rivers to Cross
J. Immunol., May 1, 2007; 178(9): 5419 - 5423.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Landais, A. Morice, H. M. Long, T. A. Haigh, B. Charreau, M. Bonneville, G. S. Taylor, and E. Houssaint
EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses
J. Immunol., August 1, 2006; 177(3): 1427 - 1433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.